These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 24926545

  • 1. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.
    Riquelme E, Suraokar MB, Rodriguez J, Mino B, Lin HY, Rice DC, Tsao A, Wistuba II.
    J Thorac Oncol; 2014 Jul; 9(7):998-1007. PubMed ID: 24926545
    [Abstract] [Full Text] [Related]

  • 2. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
    Borchert S, Suckrau PM, Walter RFH, Wessolly M, Mairinger E, Steinborn J, Hegedus B, Hager T, Herold T, Eberhardt WEE, Wohlschlaeger J, Aigner C, Bankfalvi A, Schmid KW, Mairinger FD.
    Sci Rep; 2020 Oct 29; 10(1):18677. PubMed ID: 33122816
    [Abstract] [Full Text] [Related]

  • 3. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
    Cheng YY, Kirschner MB, Cheng NC, Gattani S, Klebe S, Edelman JJ, Vallely MP, McCaughan BC, Jin HC, van Zandwijk N, Reid G.
    J Thorac Oncol; 2013 Oct 29; 8(10):1317-28. PubMed ID: 24457242
    [Abstract] [Full Text] [Related]

  • 4. Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.
    Arzt L, Halbwedl I, Gogg-Kamerer M, Popper HH.
    Pathol Oncol Res; 2017 Jul 29; 23(3):595-605. PubMed ID: 27987139
    [Abstract] [Full Text] [Related]

  • 5. PVT1 dependence in cancer with MYC copy-number increase.
    Tseng YY, Moriarity BS, Gong W, Akiyama R, Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell TC, Essig J, Otto GM, O'Sullivan MG, Largaespada DA, Schwertfeger KL, Marahrens Y, Kawakami Y, Bagchi A.
    Nature; 2014 Aug 07; 512(7512):82-6. PubMed ID: 25043044
    [Abstract] [Full Text] [Related]

  • 6. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L, Tounsi A, Berenguer-Daizé C, Dussault N, Delfino C, Benyahia Z, Cayol M, Mabrouk K, Garcia S, Martin PM, Barlesi F, Ouafik L.
    J Thorac Oncol; 2016 Jan 07; 11(1):94-107. PubMed ID: 26762744
    [Abstract] [Full Text] [Related]

  • 7. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R.
    J Pathol; 2007 Mar 07; 211(4):439-46. PubMed ID: 17253597
    [Abstract] [Full Text] [Related]

  • 8. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.
    Onen HI, Yilmaz A, Alp E, Celik A, Demiroz SM, Konac E, Kurul IC, Menevse ES.
    Hum Exp Toxicol; 2015 Feb 07; 34(2):117-26. PubMed ID: 25028262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.
    Yamamoto K, Seike M, Takeuchi S, Soeno C, Miyanaga A, Noro R, Minegishi Y, Kubota K, Gemma A.
    Oncol Rep; 2014 Dec 07; 32(6):2365-72. PubMed ID: 25231602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M, Varona-Santos J, Singh S, Robbins DJ, Savaraj N, Nguyen DM.
    J Thorac Cardiovasc Surg; 2014 Jan 07; 147(1):508-16. PubMed ID: 24094913
    [Abstract] [Full Text] [Related]

  • 13. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
    Zanellato I, Colangelo D, Osella D.
    Curr Cancer Drug Targets; 2018 Jan 07; 18(8):816-828. PubMed ID: 28669341
    [Abstract] [Full Text] [Related]

  • 14. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
    Taniguchi T, Karnan S, Fukui T, Yokoyama T, Tagawa H, Yokoi K, Ueda Y, Mitsudomi T, Horio Y, Hida T, Yatabe Y, Seto M, Sekido Y.
    Cancer Sci; 2007 Mar 07; 98(3):438-46. PubMed ID: 17270034
    [Abstract] [Full Text] [Related]

  • 15. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
    Yamaji M, Ota A, Wahiduzzaman M, Karnan S, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y, Haniuda M.
    Cancer Med; 2017 Nov 07; 6(11):2646-2659. PubMed ID: 28960945
    [Abstract] [Full Text] [Related]

  • 16. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.
    Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, Korita E, Casini B, Alessandrini G, Cambria A, Carosi MA, Blandino R, Panebianco V, Facciolo F, Visca P, Volinia S, Muti P, Strano S, Croce CM, Pass HI, Blandino G.
    Oncogene; 2014 Nov 13; 33(46):5319-31. PubMed ID: 24240684
    [Abstract] [Full Text] [Related]

  • 17. Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma.
    Mogi A, Koga K, Aoki M, Hamasaki M, Uesugi N, Iwasaki A, Shirakusa T, Tamura K, Nabeshima K.
    Virchows Arch; 2013 Jan 13; 462(1):83-93. PubMed ID: 23187830
    [Abstract] [Full Text] [Related]

  • 18. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY, Wright CM, Kirschner MB, Williams M, Sarun KH, Sytnyk V, Leshchynska I, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, van Zandwijk N, Lin RC, Reid G.
    Mol Cancer; 2016 Jun 01; 15(1):44. PubMed ID: 27245839
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1.
    Fujii Y, Amatya VJ, Kushitani K, Suzuki R, Kai Y, Kambara T, Takeshima Y.
    Oncol Rep; 2022 Feb 01; 47(2):. PubMed ID: 34859258
    [Abstract] [Full Text] [Related]

  • 20. MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
    Melaiu O, Stebbing J, Lombardo Y, Bracci E, Uehara N, Bonotti A, Cristaudo A, Foddis R, Mutti L, Barale R, Gemignani F, Giamas G, Landi S.
    PLoS One; 2014 Feb 01; 9(1):e85935. PubMed ID: 24465798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.